Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹277.80
3.25 (1.16%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹12.13K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
80.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹166+67.3%
52W High₹298-6.8%
Current Price
₹277.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹222.24
Upper Circuit₹333.36
Reference Price
₹277.80
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹286.4
Ascending Channel on 1D — target ₹286.13
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 39.14 (BUY) with 51.6% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
52%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
271.76
EMA50
253.48
EMA200
221.22
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹277.35
₹263.85
₹257.85
₹241.38
₹228.20
Volume Analysis
TrendDECREASING
Change-14.30%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹275.02
3% Risk₹269.47
5% Risk₹263.91
7% Risk (Custom)
₹258.35Technical Levels
1x ATR (Volatility)₹265.60
2x ATR (Swing)₹253.40
3x ATR (Trend)₹241.20
Immediate Support₹277.35
Moving Averages
EMA 20 (Medium-term)₹271.76
EMA 50 (Trend)₹253.48
EMA 200 (Long-term)₹221.22
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹397.3 Cr | ₹441.4 Cr | ₹424 Cr | ₹858.4 Cr |
| Net Profit | ₹9.3 Cr | ₹14.3 Cr | ₹14.7 Cr | ₹38.4 Cr |
| EPS | — | ₹0.57 | ₹0.59 | ₹0.89 |
| Operating Profit | ₹42.8 Cr | ₹54.8 Cr | ₹56.1 Cr | ₹148.4 Cr |
ROE
3.11%
ROCE
8.46%
Debt/Equity
0.68
Current Ratio
1.73
OPM
17.28%
NPM
4.48%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Viyash Scientific Limited | ₹277.80 | -1.16% | 80.7 | ₹12.13K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 08 Sept 2021 | Dividend - Rs 0.50 Per Share | DIVIDEND |
| 21 Aug 2019 | Annual General Meeting/Dividend - Rs 0.20 Per Share | AGM |
| 06 Apr 2018 | Scheme Of Arrangement | MERGER_ACQUISITION |
| 20 Nov 2017 | Interim Dividend - Re 0.20 Per Share | INTERIM_DIVIDEND |
| 15 Sept 2016 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for VIYASH
View All
neutral
ET Markets - Stocks 6d ago
Top picks! Redington among 5 stocks with upside potential of up to 27%. Do you own any?
Monarch Networth Capital has maintained Buy ratings on Pricol, Redington, Sundram Fasteners, Travel Food Services and Viyash Scientific, citing strong earnings growth, improving margins and business expansion. The brokerage sees upside potential of up to 27% across these stocks.
AKCAPITCPCAPMONARCHPRICOLLTDREDINGTONSUNDRMFASTTRAVELFOODVIYASHAutomobile and Auto ComponentsConsumer Services
positive
Business Standard - Markets 17d ago
HDFC Securities analyst flags key support levels for Nifty; 2 stocks to buy
Gland Pharma has given a breakout from a bullish 'Inverted head and shoulder' pattern, and Viyash Scientific from bullish 'Cup and handle pattern', says Vinay Rajani of HDFC Securities.
GLANDHDFCGROWTHHDFCLIQUIDHDFCMID150HDFCNEXT50HDFCNIF100HDFCNIFBANHDFCNIFITHDFCNIFTYHDFCPSUBKHDFCPVTBANHDFCSML250PHARMABEESVIYASHFinancial ServicesHealthcare
positive
Business Standard - Markets 18d ago
Stocks to buy today: Geojit recommends Viyash, Samhi, Engineers India
Anand James, chief market strategist at Geojit Investments sees up to 11% upside in Viyash Scientific, Samhi Hotels and Engineers India based on the chart set-up.
ENGINERSINSAMHIVIYASHConstructionConsumer Services